SCHEMBL5459217

SCHEMBL5459217

CC(C)(C)OC(=O)C1CN(c2ccc(N)cc2)CCCN1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.38
CASP6 P55212 1/20 0.38
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28466500 0.93 GFER (0.40) GFERCASP6MAPTALDH1A1KDM4E
SCHEMBL5473043 0.84 MAPT (0.54) MAPTALDH1A1KMT2AMEN1SLC6A3
SCHEMBL28849170 0.76 GPR119 (0.51) ALDH1A1KDM4EHSD17B10GPR119LMNA
SCHEMBL14638189 0.75 MAPT (0.41) GFERMAPTALDH1A1KDM4EGAA
SCHEMBL23157672 0.74 ADRA1D (0.41) MAPTGPR119SCN9ASCN3ASCN5A
SCHEMBL29185950 0.74 MEN1 (0.42) MAPTALDH1A1GAAKMT2AMEN1
SCHEMBL27667048 0.74 GFER (0.44) GFERCASP6MAPTALDH1A1KDM4E
SCHEMBL6073687 0.73 GPR119 (0.50) GFERCASP6MAPTALDH1A1KDM4E
SCHEMBL8986416 0.72 SLC6A2 (0.37) SCN9ASCN3ASCN5ASLC6A3
SCHEMBL16580814 0.71 MAP4K4 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 GFER 1367/4885CASP6 2577/4885MAPT 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.